Iron preparation
Control of serum phosphorus levels in patients with chronic kidney disease on dialysis
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B03 ANTIANEMIC PREPARATIONS
B03A IRON PREPARATIONS
B03AB Iron trivalent, oral preparations
B03AB02 Saccharated iron oxide
D04616 Iron sucrose (USP) <JP/US>
USP drug classification [BR:br08302]
Electrolytes/Minerals/Metals/Vitamins
Phosphate Binders
Sucroferric Oxyhydroxide
D04616 Iron sucrose (USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D04616 Iron sucrose (USP)
3 Agents affecting metabolism
32 Nutrients, tonics
322 Mineral preparations
3222 Iron compounds
D04616 Iron sucrose (USP)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Ferric oxide, saccharated
D04616 Iron sucrose (USP)
Drug groups [BR:br08330]
Blood modifier agent
DG01694 Iron preparation
D04616 Iron sucrose